{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:27:30Z","timestamp":1794684450914,"version":"4.9.1"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>comprehensive molecular characterization of adrenocortical carcinoma (ACC) through next-generation sequencing and bioinformatics analyses is expanding the number of targets with potential prognostic and therapeutic value. We performed a critical review of recent published literature on genotyping of ACC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>423 studies were published between 2019 and 2021. After manual curation we summarized selected evidence in two thematic areas: germline deoxyribonucleic acid (DNA) variations, genomic alterations and prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>the evolving genomic landscape of ACC requires target validation in terms of prognostic and predictive value within scientific consortia. Although the existing multiple driver genes are difficult targets in the perspective of precision oncology, alterations in DNA damage repair genes or in promoter hypermethylation could open new venues for repurposing of existing drugs in ACC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cco.0000000000000799","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T20:03:58Z","timestamp":1634760238000},"page":"19-28","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019\u20132021"],"prefix":"10.1097","volume":"34","author":[{"given":"Salvatore","family":"Grisanti","sequence":"first","affiliation":[{"name":"Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cosentini","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Sigala","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40618-013-0049-2","article-title":"Management of adrenal cancer: a 2013 update","volume":"37","author":"Terzolo","year":"2014","journal-title":"J Endocrinol Investig"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/cancers12040941","article-title":"Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: the Brescia experience","volume":"12","author":"Lagan\u00e0","year":"2020","journal-title":"Cancers"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coemr.2019.07.007","article-title":"Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures","volume":"8","author":"Grisanti","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1210\/jc.2014-3282","article-title":"Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma","volume":"100","author":"Juhlin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comphrehensive Pan-Genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41571-018-0002-6","article-title":"The emerging clinical relevance of genomics in cancer medicine","volume":"15","author":"Berger","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"British Med J"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2016.12.005","article-title":"Cell signaling pathways in the adrenal cortex: links to stem\/progenitor biology and neoplasia","volume":"445","author":"Penny","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"R11-20250526","doi-asserted-by":"crossref","DOI":"10.1530\/JME-18-0122","article-title":"Pathobiology and genetics of adrenocortical carcinoma","volume":"62","author":"Pittaway","year":"2019","journal-title":"J Molecular Endocrinol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coemr.2019.06.003","article-title":"cAMP\/protein kinase A signaling pathway and adrenocortical adenomas","volume":"8","author":"Ronchi","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2011.12.008","article-title":"Association of adrenocortical carcinoma with familial cancer susceptibility syndromes","volume":"351","author":"Else","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"R14-20250526","first-page":"149","article-title":"Diseases predisposing to adrenocortical malignancy (LI-Fraumeni syndrome, Beckwith-Wiedemann syndrome, and Carney complex)","volume":"111","author":"Jouinot","year":"2019","journal-title":"Exp Suppl"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/CCO.0000000000000525","article-title":"Adrenal tumors: when to search for a germline abnormality?","volume":"31","author":"Gimenez-Roqueplo","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-0358","article-title":"Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series","volume":"177","author":"Else","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.coemr.2019.07.010","article-title":"Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology","volume":"8","author":"Stratakis","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1470-2045(15)70081-1","article-title":"Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomized, phase 3 study","volume":"16","author":"Fassnacht","year":"2015","journal-title":"Lancet Oncol"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","article-title":"Adrenocortical carcinoma is a Lynch Syndrome-associated cancer","volume":"31","author":"Raymond","year":"2013","journal-title":"J Clin Oncol"},{"key":"R21-20250526","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"e126908","DOI":"10.1172\/jci.insight.126908","article-title":"PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers","volume":"4","author":"Yarchoan","year":"2019","journal-title":"JCI Insight"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"E1004","DOI":"10.1210\/jc.2011-3298","article-title":"DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors","volume":"97","author":"Rechache","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/gcc.21978","article-title":"Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors","volume":"51","author":"Fonseca","year":"2012","journal-title":"Genes Chromosom Cancer"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/cancers12051218","article-title":"Past, present and future of epigenetics in adrenocortical carcinoma","volume":"12","author":"Ettaieb","year":"2020","journal-title":"Cancers"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41574-019-0221-7","article-title":"Adrenocortical carcinoma \u2013 towards genomics guided clinical care","volume":"15","author":"Crona","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1210\/js.2018-00197","article-title":"Therapeutic targets for adrenocortical carcinoma in the genomics era","volume":"2","author":"Mohan","year":"2018","journal-title":"J Endocr Soc"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41571-019-0179-3","article-title":"Therapeutic implications of germline genetic findings in cancer","volume":"16","author":"Thavaneswaran","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1097\/MPH.0000000000001982","article-title":"Clinical outcomes of children with adrenocortical carcinoma in the context of germline TP53 status","volume":"43","author":"Brenna","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jsbmb.2019.04.011","article-title":"Clinical spectrum of Li-Fraumeni syndrome\/Li-Fraumeni-like syndrome in Brazilian inviduals with TP53 p.R337H mutation","volume":"190","author":"Ferreira","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1530\/EC-18-0526","article-title":"Adrenocortical carcinoma in patients with MEN1: a kindred report and review of literature","volume":"8","author":"Wang","year":"2019","journal-title":"Endocr Conn"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1093\/hmg\/ddaa268","article-title":"Germline EGFR variants are over-expressed in adolescents and young adults (AYA) with adrenocortical carcinoma","volume":"29","author":"Akhavanfard","year":"2021","journal-title":"Hum Mol Genet"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41416-020-0764-3","article-title":"A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence","volume":"122","author":"Surakhy","year":"2020","journal-title":"Br J Cancer"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/cancers12020506","article-title":"Germline variants in phosphodiesterase genes and genetic predisposition to pediatric adrenocortical tumors","volume":"12","author":"Pinto","year":"2020","journal-title":"Cancers"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/cancers12020359","article-title":"Effect of germline CYP2W1\u22176 and CYP2B6\u22176 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcioma: a multicenter ENSAT study","volume":"12","author":"Altieri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/js.2018-00343","article-title":"Case report of an adrenocortical carcinoma associated with germlne CHEK2 mutation","volume":"3","author":"Xie","year":"2018","journal-title":"J Endocr Soc"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/ajmg.a.62099","article-title":"Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET","volume":"185","author":"Raygada","year":"2021","journal-title":"Am J Med Genet A"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/EJE-20-1423","article-title":"A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenetic role of germline MUTYH mutation and high tumour mutational burden","volume":"184","author":"Landwehr","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1210\/js.2019-00176","article-title":"Whole-exome sequencing of syndromic adrenocortical carcinoma reveals distinct mutational profile from sporadic ACC","volume":"3","author":"Nicolson","year":"2019","journal-title":"J Endocr Soc"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"a003764","DOI":"10.1101\/mcs.a003764","article-title":"Genomic stratification and liquid biopsy in arare adrencortical carcinoma (ACC) case, with dual lung metastases","volume":"5","author":"McCabe","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1210\/js.2019-00050","article-title":"Adrenal cortical carcinoma associated with Lynch syndrome: a case report and review of literature","volume":"3","author":"Kaur","year":"2019","journal-title":"J Endocr Soc"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MPH.0000000000001205","article-title":"Composite adrenocortical carcinoma and neuroblastoma in an infant with a TP53 germline mutation: a case report and literature review","volume":"41","author":"Tang","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12020-020-02209-4","article-title":"Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant","volume":"68","author":"Gagnon","year":"2020","journal-title":"Endocrine"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/curroncol28010025","article-title":"Genomic and clinical correlates of adrenocortical carcinoma in an adult patient with Li-Fraumeni syndrome: a case report","volume":"28","author":"Bondy","year":"2020","journal-title":"Curr Oncol"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"dgaa163","DOI":"10.1210\/clinem\/dgaa163","article-title":"Cardiac myxoma caused by fumarate-hydratase gene deletion in patients with cortisol-secreting adrenocortical adenoma","volume":"105","author":"Suda","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1007\/s11033-020-05655-5","article-title":"Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors","volume":"47","author":"Feitosa","year":"2020","journal-title":"Mol Biol Rep"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1097\/MPH.0000000000001862","article-title":"Report of 2 pediatric cases with Li-Fraumeni syndrome related malignancy in a family","volume":"43","author":"Takeoka","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/clinem\/dgaa833","article-title":"Characteristics of adrenocortical carcinoma associated with Lynch Syndrome","volume":"106","author":"Domenech","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cancergen.2021.03.003","article-title":"Ataxia teleangectasia mutated germline pathogenetic variant in adrenocortical carcinoma","volume":"256-257","author":"Torres","year":"2021","journal-title":"Cancer Genet"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2018-01348","article-title":"Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication","volume":"103","author":"Lippert","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamaoncol.2019.1558","article-title":"Value of molecular classification for prognostic assessment of adrenocortical carcinoma","volume":"5","author":"Assie","year":"2019","journal-title":"JAMA Oncol"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/1078-0432.CCR-18-2693","article-title":"Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma","volume":"25","author":"Mohan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"e6555","DOI":"10.7717\/peerj.6555","article-title":"Identification of four hub genes associated with adrenocortical crcinoma progression by WGCNA","volume":"7","author":"Xia","year":"2019","journal-title":"PeerJ"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1186\/s12885-019-6389-3","article-title":"Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients","volume":"19","author":"Liang","year":"2019","journal-title":"BMC Cancer"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fendo.2019.00472","article-title":"Identification of seven aberrantly methylated and expressed genes in adrenocortical carcinoma","volume":"10","author":"Xiao","year":"2019","journal-title":"Front Endocrinol"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.surg.2018.04.080","article-title":"Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma","volume":"165","author":"Subramanian","year":"2019","journal-title":"Surgery"},{"key":"R57-20250526","first-page":"2440","article-title":"Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma","volume":"41","author":"Gao","year":"2019","journal-title":"Oncol Rep"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"173","DOI":"10.21873\/anticanres.13094","article-title":"Twist1 correlates with epithelial-mesenchymal transition markers fibronectin and vimentin in adrenocortical tumors","volume":"39","author":"Bulzico","year":"2019","journal-title":"Anticancer Res"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jtemb.2019.07.009","article-title":"Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma","volume":"56","author":"Zhu","year":"2019","journal-title":"J Trace Elem Med Biol"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"11111","DOI":"10.1111\/jcmm.15558","article-title":"Pan-cancer analysis of alternative splicing regulator heterogeneous nuclear ribonucleoproteins (hnRNPs) family and their prognostic potential","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1530\/ERC-19-0378","article-title":"The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study","volume":"27","author":"Creemers","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"R62-20250526","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EC-20-0228","article-title":"Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma","volume":"9","author":"Jouinot","year":"2020","journal-title":"Endocr Connect"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.3390\/ijms21228485","article-title":"A targeted bioinformatics assessment of adrenocortical carcinoma reveals prognostic implications of GABA system gene expression","volume":"21","author":"Knott","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R64-20250526","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.18632\/aging.102924","article-title":"Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data","volume":"12","author":"Xu","year":"2020","journal-title":"Aging"},{"key":"R65-20250526","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10637-019-00846-9","article-title":"Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours","volume":"38","author":"Dos Santos Passaia","year":"2020","journal-title":"Invest New Drugs"},{"key":"R66-20250526","doi-asserted-by":"crossref","first-page":"bvaa018","DOI":"10.1210\/jendso\/bvaa018","article-title":"IDH1 Expression via the R132H mutation-specific antibody in adrenocortical neoplasias-prognostic impact in carcinomas","volume":"4","author":"Pennanen","year":"2020","journal-title":"J Endocr Soc"},{"key":"R67-20250526","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/cam4.2774","article-title":"Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods","volume":"9","author":"B Li","year":"2020","journal-title":"Cancer Med"},{"key":"R68-20250526","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12920-020-00809-7","article-title":"Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape","volume":"13","author":"Fojo","year":"2020","journal-title":"BMC Med Genomics"},{"key":"R69-20250526","doi-asserted-by":"crossref","first-page":"671359","DOI":"10.3389\/fcell.2021.671359","article-title":"Identification and validation of a novel prognosis prediction model in adrenocortical carcinoma by integrative bioinformatics analysis, statistics, and machine learning","volume":"9","author":"Yan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R70-20250526","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41467-018-06366-z","article-title":"Metastatic adrenocortical carcinoma displays higher mutation and tumor heterogeneity than primary tumors","volume":"9","author":"Gara","year":"2018","journal-title":"Nat Commun"},{"key":"R71-20250526","doi-asserted-by":"crossref","first-page":"e928523","DOI":"10.12659\/MSM.928523","article-title":"Identification of NDRG family member 4 (NDRG4) and CDC28 protein kinase regulatory subunit 2 (CKS2) as key prognostic genes in adrenocortical carcinoma by transcriptomic analysis","volume":"27","author":"Yang","year":"2021","journal-title":"Med Sci Monit"},{"key":"R72-20250526","doi-asserted-by":"crossref","first-page":"5546612","DOI":"10.1155\/2021\/5546612","article-title":"Pancancer analysis of neurovascular-related NRP family genes as potential prognostic biomarkers of bladder Urothelial Carcinoma","volume":"2021","author":"Deng","year":"2021","journal-title":"Biomed Res Int"},{"key":"R73-20250526","doi-asserted-by":"crossref","first-page":"568397","DOI":"10.3389\/fendo.2021.568397","article-title":"Development and validation of an m6A RNA methylation regulators-based signature for predicting the prognosis of adrenocortical carcinoma","volume":"12","author":"Shen","year":"2021","journal-title":"Front Endocrinol"},{"key":"R74-20250526","doi-asserted-by":"crossref","first-page":"e25031","DOI":"10.1097\/MD.0000000000025031","article-title":"Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma","volume":"100","author":"Fu","year":"2021","journal-title":"Medicine"},{"key":"R75-20250526","doi-asserted-by":"crossref","first-page":"11919","DOI":"10.18632\/aging.202896","article-title":"Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma","volume":"13","author":"Xu","year":"2021","journal-title":"Aging"},{"key":"R76-20250526","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/ERC-21-0040","article-title":"Targeted genomic analysis of 364 adrenocortical carcinomas","volume":"28","author":"Pozdeyev","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"R77-20250526","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"R78-20250526","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2021.01.011","article-title":"Germline genetic contribution to the immune landscape of cancer","volume":"54","author":"Sayaman","year":"2021","journal-title":"Immunity"},{"key":"R79-20250526","first-page":"297","article-title":"Systems approaches to polypharmacology and drug discovery","volume":"13","author":"Boran","year":"2010","journal-title":"Curr Opin Drug Discov Dev"},{"key":"R80-20250526","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.celrep.2018.03.077","article-title":"Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers","volume":"23","author":"Peng","year":"2018","journal-title":"Cell Rep"},{"key":"R81-20250526","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coemr.2019.07.006","article-title":"New strategies for applying targeted therapies to adrenocortical carcinoma","volume":"8","author":"Mohan","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"R82-20250526","doi-asserted-by":"crossref","first-page":"613248","DOI":"10.3389\/fendo.2021.613248","article-title":"Current status and future target therapy in adrenocortical cancer","volume":"12","author":"Alyateem","year":"2021","journal-title":"Front Endocrinol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T23:06:15Z","timestamp":1748300775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000000799","relation":{},"ISSN":["1040-8746","1531-703X"],"issn-type":[{"value":"1040-8746","type":"print"},{"value":"1531-703X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}